益丰药房: 益丰药房关于2025年半年度主要经营数据的公告

Core Viewpoint - The announcement provides a summary of the key operating data for Yifeng Pharmacy Chain Co., Ltd. for the first half of 2025, highlighting a slight decrease in revenue but an increase in net profit compared to the same period last year [1]. Financial Performance - Total revenue for the first half of 2025 was approximately CNY 11.72 billion, a decrease of 0.35% compared to CNY 11.76 billion in the same period last year [1]. - Net profit attributable to shareholders was CNY 880.05 million, representing a 10.32% increase from CNY 797.72 million year-on-year [1]. - The net cash flow from operating activities decreased by 13.84% to CNY 1.57 billion from CNY 1.82 billion in the previous year [1]. - The net assets attributable to shareholders increased by 3.99% to CNY 11.15 billion from CNY 10.73 billion at the end of the previous year [1]. - Total assets decreased by 5.92% to CNY 26.32 billion from CNY 27.97 billion at the end of the previous year [1]. Key Financial Indicators - Basic earnings per share increased by 10.61% to CNY 0.73 from CNY 0.66 year-on-year [1]. - Diluted earnings per share rose by 7.58% to CNY 0.71 from CNY 0.66 year-on-year [1]. - The weighted average return on equity increased by 0.15 percentage points to 7.79% [1]. Business Segment Performance - Retail revenue was CNY 10.20 billion with a gross margin of 41.99%, showing a decrease of 1.91% in revenue compared to the previous year [2]. - The total revenue from the main business segments was CNY 11.37 billion, with a gross margin of 38.80%, reflecting a slight decrease of 0.24% year-on-year [2]. Store Network Changes - As of June 30, 2025, the company operated 14,701 stores, including 4,020 franchise stores, with a total operating area of 1.0647 million square meters [2]. - During the first half of 2025, the company opened 81 self-operated stores, closed 272 stores, and added 208 franchise stores [2]. - The company has achieved a qualification rate of 95.37% for its self-operated stores to be designated as "medical insurance designated retail pharmacies" [2].